The interplay of PICALM with APOE ε4 on Alzheimer’s disease: clues from two longitudinal cohorts and proteomic studies
Xinyu Luo, Li-Yan Gao, Liang-Yu Huang, Xiaohui Zhang, Chen‐Chen Tan, Lan Tan, Wei Xu. Translational Psychiatry, 2026-09-15
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
APOE and PICALM are prominent risk genes for late-onset Alzheimer’s disease (AD). We previously reported that the protective PICALM rs3851179 A allele was associated with slower cognitive and pathological progression among APOE ε4 carriers. However, whether this interaction affects incident AD, and through what mechanisms, remains unclear. We tested the interaction between PICALM rs3851179 and APOE ε4 on incident AD risk using multi-variable Cox models in two independent cohorts: the UK Biobank (UKB) and the Alzheimer’ s Disease Neuroimaging Initiative (ADNI). Plasma and cerebrospinal fluid (CSF) proteomics were used to explore mechanisms. In UKB, additive-scale interaction measures indicated antagonism (AP = −0.13; RERI = −0.52; SI = 0.86). Consistently, rs3851179 AG and AA genotypes were associated with lower AD risk only among APOE ε4 carriers (HR = 0.89 and 0.80, respectively). Plasma proteomics identified synaptosomal-associated protein 25 (SNAP25) as a protein associated with both APOE ε4 and PICALM rs3851179. In UKB, plasma SNAP25 levels were lower in rs3851179 AA than GG carriers ( P = 0.003) and positively associated with APOE ε4 status ( P < 0.001). Consistent though nominal associations were found in ADNI, with higher SNAP25 levels in APOE ε4 carriers ( P = 0.079) and lower levels in rs3851179 AA ( P = 0.030). No CSF protein survived the multiple-testing correction. These findings suggest that the protective effect of rs3851179 A on AD risk may be confined to APOE ε4 carriers, with SNAP25-related synaptic modulation potentially contributing to this effect.
What this study adds
Evidence grade: Low
The protective PICALM rs3851179 A allele was associated with lower Alzheimer's disease risk only among APOE ε4 carriers, and plasma SNAP25 was identified as a protein associated with both APOE ε4 and PICALM rs3851179. Reported effect size: HR = 0.89.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Luo, X., Gao, L.-Y., Huang, L.-Y., Zhang, X., Tan, C., Tan, L., et al. (2026). The interplay of PICALM with APOE ε4 on Alzheimer’s disease: clues from two longitudinal cohorts and proteomic studies. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04453-0
Vancouver
Luo X, Gao L.-Y, Huang L.-Y, Zhang X, Tan C, Tan L, et al. The interplay of PICALM with APOE ε4 on Alzheimer’s disease: clues from two longitudinal cohorts and proteomic studies. Translational Psychiatry. 2026. doi:10.1038/s41398-026-04453-0.
BibTeX
@article{luo2026-0e28a66d,
author = {Luo, Xinyu and Gao, Li-Yan and Huang, Liang-Yu and Zhang, Xiaohui and Tan, Chen‐Chen and Tan, Lan and Xu, Wei},
title = {{The interplay of PICALM with APOE ε4 on Alzheimer’s disease: clues from two longitudinal cohorts and proteomic studies}},
journal = {Translational Psychiatry},
year = {2026},
doi = {10.1038/s41398-026-04453-0},
url = {https://doi.org/10.1038/s41398-026-04453-0}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- We previously reported that the protective PICALM rs3851179 A allele was associated with slower cognitive and pathological progression among APOE ε4 carriers.
- Consistently, rs3851179 AG and AA genotypes were associated with lower AD risk only among APOE ε4 carriers (HR = 0.89 and 0.80, respectively).
- Plasma proteomics identified synaptosomal-associated protein 25 (SNAP25) as a protein associated with both APOE ε4 and PICALM rs3851179.
- In UKB, plasma SNAP25 levels were lower in rs3851179 AA than GG carriers ( P = 0.003) and positively associated with APOE ε4 status ( P < 0.001).
- These findings suggest that the protective effect of rs3851179 A on AD risk may be confined to APOE ε4 carriers, with SNAP25-related synaptic modulation potentially contributing to this effect.
Why it matters
The protective PICALM rs3851179 A allele was associated with lower Alzheimer's disease risk only among APOE ε4 carriers, and plasma SNAP25 was identified as a protein associated with both APOE ε4 and PICALM rs3851179. No CSF protein survived multiple-testing correction.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Effect sizeHR = 0.89
- Evidence strengthLow
How this study scored 34/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Translational Psychiatry) |
| Journal's citation record | 2 / 4 | Translational Psychiatry: journal h-index 180 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Wei Xu: h-index 42 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Qingdao University: institution h-index 430 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.